Lucas Capital Management boosted its position in Express Scripts Holding Co. (NASDAQ:ESRX) by 4.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,036 shares of the company’s stock after buying an additional 280 shares during the period. Lucas Capital Management’s holdings in Express Scripts Holding were worth $458,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in the company. Savant Capital LLC purchased a new position in Express Scripts Holding during the second quarter worth approximately $336,000. Baltimore Washington Financial Advisors Inc. boosted its stake in Express Scripts Holding by 1.1% in the second quarter. Baltimore Washington Financial Advisors Inc. now owns 83,484 shares of the company’s stock valued at $6,328,000 after buying an additional 930 shares during the period. Northern Capital Management LLC boosted its stake in Express Scripts Holding by 11.3% in the second quarter. Northern Capital Management LLC now owns 23,620 shares of the company’s stock valued at $1,790,000 after buying an additional 2,400 shares during the period. First National Trust Co. boosted its stake in Express Scripts Holding by 15.6% in the second quarter. First National Trust Co. now owns 4,703 shares of the company’s stock valued at $356,000 after buying an additional 636 shares during the period. Finally, BloombergSen Inc. boosted its stake in Express Scripts Holding by 5.4% in the second quarter. BloombergSen Inc. now owns 1,396,497 shares of the company’s stock valued at $105,854,000 after buying an additional 71,949 shares during the period. 88.52% of the stock is owned by hedge funds and other institutional investors.
Shares of Express Scripts Holding Co. (NASDAQ:ESRX) traded down 0.41% during mid-day trading on Friday, reaching $70.06. 3,437,822 shares of the company were exchanged. The stock has a market capitalization of $44.15 billion, a P/E ratio of 17.31 and a beta of 1.16. Express Scripts Holding Co. has a 12 month low of $65.55 and a 12 month high of $89.20. The stock has a 50 day moving average price of $71.94 and a 200-day moving average price of $73.70.
Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings results on Monday, July 25th. The company reported $1.57 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.57. Express Scripts Holding had a net margin of 2.64% and a return on equity of 23.98%. The company earned $25.20 billion during the quarter, compared to the consensus estimate of $25.42 billion. During the same quarter in the previous year, the firm earned $1.44 earnings per share. The firm’s quarterly revenue was down .9% on a year-over-year basis. Analysts predict that Express Scripts Holding Co. will post $6.36 earnings per share for the current year.
ESRX has been the subject of several research reports. Zacks Investment Research cut shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Thursday, August 4th. Leerink Swann restated a “market perform” rating and issued a $80.00 price target on shares of Express Scripts Holding in a report on Thursday, September 1st. Barclays PLC boosted their price target on shares of Express Scripts Holding from $85.00 to $87.00 and gave the company an “overweight” rating in a report on Wednesday, July 27th. Sanford C. Bernstein began coverage on shares of Express Scripts Holding in a report on Thursday, June 16th. They issued an “underperform” rating and a $68.00 price target for the company. Finally, Jefferies Group reduced their price target on shares of Express Scripts Holding from $98.00 to $88.00 and set a “buy” rating for the company in a report on Tuesday, July 26th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and nine have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $81.53.
In other Express Scripts Holding news, VP Christopher A. Mcginnis sold 1,785 shares of the firm’s stock in a transaction that occurred on Monday, September 12th. The shares were sold at an average price of $70.77, for a total transaction of $126,324.45. Following the sale, the vice president now owns 4,955 shares of the company’s stock, valued at $350,665.35. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Woodrow A. Myers, Jr. sold 12,036 shares of the firm’s stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $70.40, for a total transaction of $847,334.40. Following the sale, the director now directly owns 14,918 shares in the company, valued at approximately $1,050,227.20. The disclosure for this sale can be found here. 0.54% of the stock is currently owned by corporate insiders.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co. (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Holding Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Co. and related companies with MarketBeat.com's FREE daily email newsletter.